Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion Corporation

  Law Firm Brower Piven Announces Investigation of Investor Securities Fraud
  Against Celsion Corporation

Business Wire

STEVENSON, Md. -- January 31, 2013

The law firm of Brower Piven, A Professional Corporation, is investigating
potential securities fraud claims against Celsion Corporation (“Celsion”)
(NASDAQ: CLSN) regarding whether Celsion may have issued materially false or
misleading information to investors before announcing on January 31, 2013 that
its ThermoDox liver cancer treatment failed in a study and did not meet its
primary endpoint.

If you purchased or acquired Celsion securities between January 1, 2012 and
January 30, 2013 and have suffered a loss on your investment, or if you
believe you have information relating to the subject matter of our
investigation, you may email or call Brower Piven, who will, without
obligation or cost to you, communicate with you regarding the matter and
attempt to answer your questions. You may contact Brower Piven by email at
hoffman@browerpiven.com, by calling 410/415-6616, or by writing to Brower
Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland
21153. Attorneys at Brower Piven have combined experience litigating
securities and other class action cases of over 60 years.

Contact:

Brower Piven, A Professional Corporation
Stevenson, Maryland
Charles J. Piven, 410-415-6616
hoffman@browerpiven.com
 
Press spacebar to pause and continue. Press esc to stop.